We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01328457
First Posted: April 4, 2011
Last Update Posted: April 4, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
International Centre for Diarrhoeal Disease Research, Bangladesh
Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh
GVK Biosciences Private Limited, Gurgaon, India
Information provided by (Responsible Party):
PATH
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):